Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03518554 |
| Title | A First in Human, Dose Escalation Study of JAB-3068 in Adult Patients With Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Jacobio Pharmaceuticals Co., Ltd |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HealthONE Clinic Services Oncology-Hematology | Denver | Colorado | 80202 | United States | Details | |
| Florida Cancer Specialists | Sarasota | Florida | 37203 | United States | Details | |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
| The University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |